Innovation Now for Follicular Lymphoma: New Evidence for Immunotherapy, Targeted, and Chemo-Free Options
•Télécharger en tant que PPT, PDF•
0 j'aime•54 vues
Chair, Loretta J. Nastoupil, MD, discusses lymphoma in this CME/MOC activity titled “Innovation Now for Follicular Lymphoma: New Evidence for Immunotherapy, Targeted, and Chemo-Free Options.” For the full presentation and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3EPpEBa. CME/MOC credit will be available until February 1, 2024.
